Abstract
Research in the past 2 decades showed that attention-deficit/hyperactivity disorder (ADHD) is a frequently occurring psychiatric disorder that causes considerable suffering to patients and their families. This article outlines current pharmacologic ADHD treatment options and focuses on their safety profile and efficacy. In addition, it addresses treatment selection, guidelines for monitoring treatment, and recent controversies in the field.
Original language | English |
---|---|
Pages (from-to) | 99-120 |
Number of pages | 22 |
Journal | Pediatric Clinics of North America |
Volume | 58 |
Issue number | 1 |
DOIs | |
State | Published - Feb 2011 |
Keywords
- ADHD
- Atomoxetine
- Guanfacine
- Pharmacotherapy
- Stimulants